Guangzhou Wondfo Biotech Co Ltd300482
▲ PositiveCapitalrelevance
Company repurchased shares, signaling confidence and supporting stock price.

Wondfo Biotech announced that as of July 31, 2026, the company had repurchased a cumulative 1.74 million shares through centralized competitive trading, representing 0.3708% of total share capital. The repurchase price ranged from 16.65 yuan to 17.5 yuan per share, with a total repurchase amount of 30.01 million yuan. In the first quarter of 2026, the company achieved revenue of 582 million yuan and net profit attributable to the parent of 84.4 million yuan.
Guangzhou Wondfo Biotech Co LtdCompany repurchased shares, signaling confidence and supporting stock price.